| Regulation Number | 878.4400 |
|---|---|
| Classification Product Code | GEI |
| Regulation Medical Specialty | General & Plastic Surgery |
| 510k Review Panel | General & Plastic Surgery |
| Date Received | 08/13/2021 |
|---|---|
| Decision Date | 09/27/2022 |
| Decision | Substantially Equivalent (SESE) |
| Summary | Summary |
| Type | Traditional |
| Reviewed by Third Party | No |
| Combination Product | No |
Page Last Updated: 12/20/2024 — Source: FDA.gov 510(k) Premarket Notification Database
This page contains FDA website navigation links and footer information from the official 510(k) Premarket Notification database printout. The notification record confirms that MTX-C1 (K212561) received a Substantially Equivalent (SESE) determination on September 27, 2022, clearing the device for marketing in the United States.